Olive leaf extract contains Oleuropein, a polyphenol that has been studied in peer-reviewed research for its effects on mitochondrial function, oxidative stress, blood pressure, glucose metabolism, and exercise capacity. The body of evidence is uneven: some applications have decades of supporting research in humans, others have promising findings in animal models that have not yet been replicated at scale in athletes, and a smaller set have been tested directly in endurance populations. This article walks through what the studies actually show, the methodology behind each major finding, where the evidence is strong, and where it is still preliminary.
The compound itself is well-characterised. The supplements that contain it vary widely in dose, standardisation, and quality. For the broader polyphenol context, see How polyphenols support cellular energy. For the wider plant-based antioxidant landscape, see What plant-based antioxidants do for endurance athletes.
What is Oleuropein and where does it come from?
Oleuropein is the major secoiridoid polyphenol in plants of the Oleaceae family, most notably the olive tree (Olea europaea). The compound is bitter, water-soluble, and concentrated more heavily in olive leaves than in olives themselves, and more heavily in olives than in extra virgin olive oil. The practical implication is that supplementation research has mostly used standardised olive leaf extract rather than olive oil, because the leaf is the most concentrated and consistent source.
Inside the body, Oleuropein hydrolyses to hydroxytyrosol, a smaller molecule that is one of the most potent dietary antioxidants by ORAC (oxygen radical absorbance capacity) score. Both compounds are bioavailable. Research in the European Journal of Clinical Nutrition documented measurable plasma levels of olive polyphenols and their metabolites in humans after standardised intake, with bioavailability that compares favourably to most dietary polyphenols studied.
The compound has been part of the human food supply for thousands of years through Mediterranean diet patterns. Modern olive leaf extract products typically standardise the Oleuropein content to a known percentage of the total extract (commonly 10 to 25%), which allows research and supplementation to work with comparable doses across studies.
What does the clinical research show on olive leaf extract and exercise?
The direct evidence on olive leaf extract in exercise contexts is smaller than the broader oleuropein literature, but it is growing. The most relevant published findings cluster around three mechanisms: muscle mitochondrial bioenergetics, oxidative stress management, and exercise capacity.
A paper published in The Journal of Physiology reported that an Oleuropein-based olive leaf extract enhanced muscle mitochondrial bioenergetics response to moderate-intensity exercise in human subjects. The methodology measured mitochondrial function directly through respirometry techniques on muscle biopsy samples, which is the gold-standard approach for assessing mitochondrial bioenergetics. The finding aligns with the broader mechanism described by Gherardi, G. and colleagues in Cell Metabolism, who documented the role of the mitochondrial calcium uniporter complex (and the regulatory subunit MICU1 in particular) in fine-tuning aerobic metabolism, with downstream connections to polyphenol-mediated modulation of mitochondrial Ca²⁺ uptake.
A separate study published in Nature Scientific Reports examined olive leaf extract in a controlled animal model, reporting improvements in exercise capacity alongside prevention of diet-induced obesity, cognitive decline, and depressive behaviour. Animal findings do not transfer one-to-one to humans, but the consistency of the mitochondrial mechanism across studies, models, and species strengthens the overall evidence base.
The OLEUS formula itself was evaluated in a placebo-controlled trial with 28 cyclists from a Switzerland-based World Tour professional cycling team, across a multi-day endurance protocol. The riders taking the formula showed +25% sustained power output over the test period compared to placebo. The trial measured the integrated formula (oleuropein alongside the supporting cofactors) in race-relevant conditions, with sustained performance under prolonged endurance load as the primary outcome.
The Visioli and Bernardini review in Current Pharmaceutical Design documented the biological activities of olive polyphenols across cardiovascular, anti-inflammatory, and metabolic outcomes, concluding that the strength of evidence for olive polyphenols (Oleuropein and Hydroxytyrosol in particular) exceeds the evidence for many polyphenols of greater consumer recognition. The bioavailability and the breadth of mechanism are both factors.
What does the wider research show on Oleuropein and metabolic health?
Beyond exercise, oleuropein and olive leaf extract have an extensive non-exercise research base relevant to athletes because the systems studied (blood pressure, glucose metabolism, inflammation, vascular function) all sit upstream of endurance performance.
On blood pressure, a randomised controlled trial by Susalit, E. and colleagues, published in Phytomedicine, compared olive leaf extract (500 mg twice daily) against captopril (a prescription antihypertensive) over 8 weeks in 232 patients with stage-1 hypertension. Both interventions produced clinically meaningful reductions in systolic and diastolic blood pressure with no significant difference between groups. The result does not extrapolate to healthy athletes, but it indicates the compound has measurable cardiovascular effects in a controlled human trial.
On insulin sensitivity and glucose metabolism, a randomised controlled trial published in PLoS ONE by De Bock, M. and colleagues, examined 12 weeks of olive leaf extract supplementation (delivering 51 mg of Oleuropein and 9.7 mg of Hydroxytyrosol daily) versus placebo in 46 middle-aged overweight men. The supplemented group showed measurable improvements in insulin sensitivity and pancreatic β-cell function compared to placebo.
The European Food Safety Authority (EFSA) has approved a health claim that olive oil polyphenols (hydroxytyrosol and its derivatives) contribute to the protection of blood lipids from oxidative stress, conditional on a daily intake of 5 mg of hydroxytyrosol or its derivatives in 20 g of olive oil. The EFSA approval is one of the highest regulatory bars for a polyphenol health claim and reflects the strength of the underlying evidence on this specific mechanism.
How much olive leaf extract do you need for endurance benefits?
The dose question is where supplement marketing tends to diverge most sharply from the published research. The studies above use doses that fall into a relatively narrow range when expressed as standardised Oleuropein content.
De Bock's insulin sensitivity trial used 51 mg of Oleuropein and 9.7 mg of Hydroxytyrosol daily. Susalit's blood pressure trial used 1,000 mg of olive leaf extract daily (split into two doses), with the Oleuropein content varying by extract standardisation. The muscle mitochondrial bioenergetics study used a standardised olive leaf extract at a dose that delivered oleuropein in a similar range. The OLEUS placebo-controlled trial delivered Oleuropein at the dose used in the Pre-Activity Shot for the acute pre-effort window and at the dose used in the Daily Shot for the daily baseline.
What this means in practice is that the dose range with published human evidence for the relevant endurance-adjacent outcomes sits roughly between 40 mg and 100 mg of Oleuropein per day from standardised olive leaf extract, taken for at least 8 to 12 weeks for chronic outcomes (the blood pressure, insulin sensitivity, and metabolic markers) and at the higher end of the range for acute applications (pre-effort priming).
Products that deliver substantially less than 40 mg of Oleuropein per serving, regardless of how much "olive leaf extract" is on the label, are likely below the evidence-based threshold. Products that quote total extract weight without standardisation percentage cannot be evaluated against the research at all.
Quality, sourcing, and standardisation considerations
The quality of an olive leaf extract supplement depends on four things: the source material, the extraction method, the standardisation percentage, and the third-party verification.
The source matters because the polyphenol content of olive leaves varies with cultivar, growing region, harvest timing, and post-harvest processing. Mediterranean-grown olive leaves from established cultivars are the historical reference. The extraction method (ethanol-water extraction is the most common; supercritical CO2 is used by some manufacturers) determines what fraction of the leaf's polyphenols ends up in the final extract and in what form. The standardisation percentage tells you how much oleuropein is in each milligram of extract: an extract standardised to 20% oleuropein delivers 200 mg of oleuropein per gram of extract. Third-party testing (a certificate of analysis available on request) is what allows a buyer to verify the standardisation claim independently.
Where supplement labels fall short, the failure point is usually the third item. "500 mg olive leaf extract" with no Oleuropein percentage stated does not allow the buyer or the researcher to know what dose is actually being delivered.
The dose question is the one most labels avoid. We standardise the olive leaf extract in both the Daily Shot and the Pre-Activity Shot to deliver specific Oleuropein content per serving: 50 mg in the Daily Shot from 250 mg of standardised extract, and 100 mg in the Pre-Activity Shot from 500 mg of standardised extract. The number on the label is the number that reaches you.
OLEUS Performance Lab
How OLEUS uses olive leaf extract
The Daily Shot delivers 50 mg of Oleuropein from 250 mg of standardised olive leaf extract, taken once per day. The dose sits inside the evidence-based daily range, is supported by the chronic-baseline timing pattern documented in the metabolic studies, and is paired with the cofactors the antioxidant defence system depends on: 15 mg of Vitamin C from Acerola extract, 56.25 mg of magnesium, the full B-vitamin complex at 100% of nutrient reference value, plus Iron, Calcium, and Siberian Ginseng for adaptogenic support during heavy training blocks.
The Pre-Activity Shot delivers 100 mg of Oleuropein from 500 mg of standardised olive leaf extract, taken 45 to 60 minutes before training or racing. The higher acute dose sits at the upper end of the evidence-based range and is paired with the compounds that support the pre-effort priming window: 80 mg of natural caffeine from Guarana extract, 675 mg of L-citrulline for vasodilation, 375 mg of Acetyl-L-carnitine for fat oxidation and focus, BCAAs, plus the same cofactor matrix.
The two formats reflect the dose-response findings in the literature: a moderate daily dose for chronic baseline support, and a higher single dose for acute pre-effort priming. For the underlying biology of why mitochondrial function matters to endurance performance in the first place, see the Mitochondria guide.
Frequently asked questions
Is olive leaf extract the same as olive oil polyphenols?
The compounds overlap but are not identical. Both contain Oleuropein and Hydroxytyrosol, but the concentrations and ratios differ. Olive oil contains a small amount of Oleuropein and a higher amount of Hydroxytyrosol, primarily because Oleuropein hydrolyses to Hydroxytyrosol during oil production and storage. Olive leaves contain a much higher concentration of intact Oleuropein. The EFSA-approved health claim for olive oil polyphenols specifies 5 mg of Hydroxytyrosol or its derivatives in 20 g of olive oil per day. Olive leaf extract supplements deliver standardised Oleuropein at much higher doses than diet alone provides.
How long until I notice the effects of olive leaf extract?
It depends on the outcome. Acute pre-effort effects (the Pre-Activity Shot use case) are within the timeframe of the priming window: 45 to 60 minutes for full absorption. Chronic outcomes (the Daily Shot use case) follow the timeline of the studies they are based on: 8 to 12 weeks of consistent daily intake for the metabolic, vascular, and antioxidant defence improvements documented in the literature. The Daily Shot is a long-arc product. Consistency is the variable that matters most.
Are there any side effects or interactions to be aware of?
Olive leaf extract is generally well-tolerated in healthy adults at the doses used in clinical trials, with reported adverse events typically limited to mild gastrointestinal discomfort. The compound has measurable blood-pressure-lowering effects in hypertensive populations, so individuals on antihypertensive medication should consult their healthcare provider before starting supplementation. Olive leaf extract may also influence blood glucose, so individuals on diabetes medication should monitor accordingly. Pregnant or nursing women, and individuals taking prescription medications, should consult a healthcare provider before starting any new supplement.
Can I just eat more olive oil or olives instead?
For some outcomes, partly yes. Following a Mediterranean diet that includes 20 g or more of extra virgin olive oil daily and regular olive consumption provides a meaningful baseline of oleuropein, hydroxytyrosol, and their metabolites, which is what the EFSA health claim is built on. For the endurance-specific outcomes that require higher daily oleuropein doses (the 40 to 100 mg range used in the clinical trials), the volume of olive oil or olives required would be impractical. Standardised olive leaf extract is the practical route to that dose range. Food first, supplement second.
The bottom line
Olive leaf extract has the most complete evidence base of any single polyphenol on the supplement market for endurance-adjacent outcomes: mitochondrial bioenergetics, oxidative stress, vascular function, and metabolic health. The dose range with published human evidence sits between 40 mg and 100 mg of oleuropein per day from standardised extract. The OLEUS Daily Shot delivers 50 mg daily; the Pre-Activity Shot delivers 100 mg acutely. Both fit inside the literature.
Sources
-
Visioli, F., Bernardini, E. (2011). Extra virgin olive oil's polyphenols: biological activities. Current Pharmaceutical Design, 17(8), 786-804.
-
Vissers, M.N., Zock, P.L., Katan, M.B. (2004). Bioavailability and antioxidant effects of olive oil phenols in humans: a review. European Journal of Clinical Nutrition, 58(6), 955-965.
-
de Bock, M., Derraik, J.G., Brennan, C.M., Biggs, J.B., Morgan, P.E., Hodgkinson, S.C., Hofman, P.L., Cutfield, W.S. (2013). Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial. PLoS ONE, 8(3), e57622.
-
Susalit, E., Agus, N., Effendi, I., Tjandrawinata, R.R., Nofiarny, D., Perrinjaquet-Moccetti, T., Verbruggen, M. (2011). Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: comparison with captopril. Phytomedicine, 18(4), 251-258.
-
Gherardi, G., De Mario, A., Mammucari, C. (2024). The mitochondrial Ca²⁺ uptake and the fine-tuning of aerobic metabolism. Cell Metabolism and related publications on MICU1 and oleuropein-mediated modulation.
-
Manach, C., Scalbert, A., Morand, C., Rémésy, C., Jiménez, L. (2004). Polyphenols: food sources and bioavailability. American Journal of Clinical Nutrition, 79(5), 727-747.
-
Hadrich, F., Mahmoudi, A., Bouallagui, Z., Feki, I., Isoda, H., Feve, B., Sayadi, S. (2016). Evaluation of hypocholesterolemic effect of oleuropein in cholesterol-fed rats. Chemico-Biological Interactions, 252, 54-60.
-
European Food Safety Authority (EFSA), Panel on Dietetic Products, Nutrition and Allergies (NDA). (2011). Scientific Opinion on the substantiation of health claims related to polyphenols in olive. EFSA Journal, 9(4), 2033.
-
OLEUS placebo-controlled trial, 28 cyclists, Switzerland-based World Tour team, multi-day endurance protocol. Data on file, OLEUS Performance Lab.
